This inventor holds 9 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents. Top assignee: Alligator Bioscience Ab. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2026
Title: The Innovations of Niina Veitonmaki: Pioneering Bispecific Polypeptides
Introduction
Niina Veitonmaki, an innovative inventor based in Lund, Sweden, has made significant contributions to the field of biotechnology. With a portfolio that includes seven patents, she is recognized for her cutting-edge work in developing bispecific polypeptides and therapeutic antibodies, which have potential applications in treating critical diseases such as cancer.
Latest Patents
Among her notable inventions, Niina’s latest patents include advancements in bispecific polypeptides. This invention describes the creation of bispecific antibodies that feature distinct binding domains capable of targeting two different T cell markers simultaneously. This dual-target approach may enhance immune response against various diseases.
Another significant patent centers on anti-CD137 antibodies, which are engineered to inhibit the binding of reference antibodies to human CD137. This innovation provides promising avenues for developing treatments for cancer and includes various pharmaceutical compositions and methods for utilizing these antibodies in clinical settings.
Career Highlights
Niina Veitonmaki is currently associated with Alligator Bioscience AB, a company that focuses on developing innovative therapies for cancer treatment. Her work exemplifies a commitment to advancing therapeutic options through her expertise in antibody technology and polypeptide research. The impact of her inventions is evident in the ongoing evolution of treatment modalities in oncology.
Collaborations
Throughout her career, Niina has collaborated with esteemed colleagues, including Peter Ellmark and Sara Fritzell. These partnerships illustrate the combined efforts of skilled professionals dedicated to pioneering new solutions in the biotechnology landscape.
Conclusion
In conclusion, Niina Veitonmaki's contributions to the field of biotechnology through her innovative patents are noteworthy. Her work on bispecific polypeptides and anti-CD137 antibodies highlights the potential to transform cancer therapies and offers hope for many patients. As a dedicated inventor at Alligator Bioscience AB, Niina continues to push the boundaries of scientific discovery and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile